Mother’s diet in pregnancy leaves life-long afterglow for offspring

 31 January 2017   Research News

Scientists at the London Institute of Medical Sciences (MRC LMS) have developed a detailed visual demonstration that poor diet during pregnancy can cause biological changes that last throughout life.

The study, published today in Cell Reports, showed that when pregnant mice were fed a diet deficient in protein this interfered with the expression of genes within the embryo that are known to be important for healthy growth.

The impact of adversity, such as a poor diet in early life, and whether this might cause lasting effects has long intrigued scientists. There have been suggestions that the children of women pregnant during famines, for example, may suffer harmful effects later in life. This new study offers a new way to visualise such effects and possible ways to counter these.

The green glow shows the imprinted gene. It is clearly visible in the cartilage, spine, brain, developing pancreas and stomach when inherited from the mother (left), but is “silent” when inherited from the father (right). For comparison, an embryo with no glowing enzyme is shown in the central image.

Source: Professor Paul French, Imperial College London, Imperial Photonics

The research team, led by director of the LMS Amanda Fisher, developed novel imaging techniques that allowed them to visualise genes as they were switched “on” or “off” in mouse embryos as they grew (see images). This enabled the research group to see exactly where alterations in response to maternal diet were happening and, crucially, when during pregnancy key changes took place.

Understanding how genes are controlled and kept “on” or “off” is a relatively new field of science known as “epigenetics”. This is the first time such epigenetic effects have been visualised during development in this way, using a simple but powerful bioluminescent imaging approach. The team attached enzymes from fireflies (luciferase) or bacteria (beta-galactosidase) onto the gene they were studying, and watched how this produced a glow (green in images) as the gene was turned “on” in mice.

The research focused on a group of genes called “imprinted” genes, and on one in particular known as Cdkn1c. Imprinted genes are intriguing because although a copy of the gene is inherited from each parent, as usual, only one of these copies is active. The other copy is kept idle, or “silenced”. In the case of Cdkn1c, only the copy inherited from the mother is active.

Using their new visualising technique, the team showed that if a mouse carried the copy of the gene from the father, which is “silenced”, then it could not be seen. If they used either diet or drugs to re-activate it, they were able to see the gene glow. The researchers expect that this new way to “see” when imprinted genes are active or silent will prove valuable for many other scientists who are investigating epigenetic effects in our bodies.

“There are around a 100 imprinted genes, about 0.4% of the total in the genome, and most appear to have their greatest impact during pregnancy. The pattern by which imprinted genes are ‘set’ in early life plays an important part in the development of healthy offspring. If a gene is ‘miss-set’ then problems may occur later,” says Mathew Van de Pette, first author on the paper and member of the Lymphocyte Development group at LMS. “We found that mice fed a low protein diet in pregnancy produced offspring in which the father’s copy of the gene became active and stayed that way. This demonstrates a clear link between early life adversity and later life outcomes.”

“We were surprised that this change in diet permanently affected the expression of this imprinted gene,” said Amanda Fisher. “Our work suggests there may be a window of vulnerability when diet can indeed have an effect, and that once these genes are set, they’re set for life,” Fisher said. “The good news is that we’ve also shown that it’s possible to avoid this with a normal diet”.

Notes: Study participants included Rosalind John at the Cardiff University, and Paul French at Imperial College London. The work was funded by the Medical Research Council and the European Research Council, with institutional support to Imperial College London from the Wellcome Trust, NIHR.


Susan Watts

Head of Communications and Public Engagement
MRC London Institute of Medical Sciences (LMS)
Hammersmith Hospital campus
Du Cane Road, London W12 0NN
T: +44 (0) 208 3838247
M: +44 (0) 7590 250652

MRC London Institute of Medical Sciences
is the new name of the MRC Clinical Sciences Centre